Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)Depreciation ExpenseLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetRevenue - OtherRevenue - RentalShares Issued
Ratios

Maxcyte (MXCT) Depreciation & Amortization (IS) (2021 - 2025)

Maxcyte (MXCT) has disclosed Depreciation & Amortization (IS) for 5 consecutive years, with $1.0 million as the latest value for Q4 2025.

  • Quarterly Depreciation & Amortization (IS) rose 2.06% to $1.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $4.2 million through Dec 2025, up 2.0% year-over-year, with the annual reading at $4.2 million for FY2025, 2.0% up from the prior year.
  • Depreciation & Amortization (IS) for Q4 2025 was $1.0 million at Maxcyte, roughly flat from $1.0 million in the prior quarter.
  • The five-year high for Depreciation & Amortization (IS) was $1.1 million in Q2 2025, with the low at $311600.0 in Q1 2021.
  • Average Depreciation & Amortization (IS) over 5 years is $811555.0, with a median of $998500.0 recorded in 2023.
  • The sharpest move saw Depreciation & Amortization (IS) surged 128.96% in 2022, then fell 4.05% in 2024.
  • Over 5 years, Depreciation & Amortization (IS) stood at $381600.0 in 2021, then soared by 128.96% to $873700.0 in 2022, then increased by 21.67% to $1.1 million in 2023, then fell by 4.05% to $1.0 million in 2024, then increased by 2.06% to $1.0 million in 2025.
  • According to Business Quant data, Depreciation & Amortization (IS) over the past three periods came in at $1.0 million, $1.0 million, and $1.1 million for Q4 2025, Q3 2025, and Q2 2025 respectively.